Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Literature
1.
Romito F, Cormio C, Giotta F, Colucci G, Mattioli V (2012) Quality of life, fatigue and depression in Italian long-term breast cancer survivors. Support Cancer Care. doi:10.​1007/​s00520-012-1424-9
2.
Roth AJ, Nelson C, Rosenfeld B et al (2010) Methylphenidate for fatigue in ambulatory men with prostate cancer. Cancer 116:5102–5110PubMedCrossRef
3.
Cueva JF, Calvo M, Anido U et al (2012) Methylphenidate in the management of asthenia in breast cancer patients treated with docetaxel: results of a pilot study. Invest New Drugs 30:688–694PubMedCrossRef
4.
Johnson RL, Block I, Gold MA, Markwell S, Zupancic M (2010) Effect of methylphenidate on fatigue in women with recurrent gynecologic cancer. Psychooncology 19:955–958PubMedCrossRef
5.
Bruera E, Valero V, Driver L et al (2006) Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial. J Clin Oncol 24:2073–2078PubMedCrossRef
6.
Yennurajalingam S, Palmer JL, Chacko R, Bruera E (2011) Factors associated with response to methylphenidate in advanced cancer patients. Oncologist 16:246–253PubMedCrossRef
Metadata
Title
Methylphenidate for the amelioration of cancer-associated fatigue
Author
Shailendra Kapoor
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 10/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1488-6

Other articles of this Issue 10/2012

Supportive Care in Cancer 10/2012 Go to the issue

Original Article

Oral mucositis in pediatric and adolescent patients undergoing chemotherapy: the impact of symptoms on quality of life

Original Article

Attachment styles in patients with lung cancer and their spouses: associations with patient and spouse adjustment

Original Article

Promoting calcium and vitamin D intake to reduce the risk of osteoporosis in men on androgen deprivation therapy for recurrent prostate cancer

Original Article

Comparison of two dosing schedules of palonosetron for the prevention of nausea and vomiting due to interleukin-2-based biochemotherapy

Original Article

Cardiac effects of granisetron in a prospective crossover randomized dose comparison trial

Original Article

Creation of a questionnaire to measure stress among nurses engaged in palliative care on general wards
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits